Institution statistics

DEUTSCHES KREBSFORSCHUNGSZENTRUM - Germany 

Ranking results:

Past rankings:
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2017
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:100-200
Total Number of Projects:300-400
Networking Rank (Reputation):600-700
2016
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:200-300
Total Number of Projects:500-600
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:200-300
Total Project Funding per Partner:200-300
Total Number of Projects:400-500
Networking Rank (Reputation):> 1000
Partner Constancy:300-400
Project Leadership Index:82
2013
Criterium:Position:
Overall Score:300-400
Total Project Funding:300-400
Total Project Funding per Partner:200-300
Total Number of Projects:64
Partner Constancy:58
Project Leadership Index:47
Diversity Index:47
2012
Criterium:Position:
Overall Score:500-600
Total Project Funding:200-300
Total Project Funding per Partner:100-200
Total Number of Projects:61
Networking Rank (Reputation):300-400
Networking Rank (Reputation):300-400
Partner Constancy:46
Project Leadership Index:75
Diversity Index:37
2011
Criterium:Position:
Overall Score:600-700
Total Project Funding:400-500
Total Project Funding per Partner:400-500
Total Number of Projects:300-400
Networking Rank (Reputation):400-500
Partner Constancy:700-800
Project Leadership Index:200-300
Diversity Index:> 1000
2010
Criterium:Position:
Overall Score:> 1000
Total Project Funding:400-500
Total Project Funding per Partner:100-200
Total Number of Projects:500-600
Networking Rank (Reputation):> 1000
Partner Constancy:500-600
Project Leadership Index:600-700
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:400-500
Total Project Funding:200-300
Total Project Funding per Partner:100-200
Total Number of Projects:200-300
Networking Rank (Reputation):200-300
Partner Constancy:600-700
Project Leadership Index:600-700
Diversity Index:300-400
2008
Criterium:Position:
Overall Score:300-400
Total Project Funding:100-200
Total Project Funding per Partner:100-200
Total Number of Projects:200-300
Networking Rank (Reputation):200-300
Partner Constancy:200-300
Project Leadership Index:300-400
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:900-1000
Total Project Funding:300-400
Total Project Funding per Partner:100-200
Total Number of Projects:200-300
Networking Rank (Reputation):400-500
Partner Constancy:500-600
Project Leadership Index:600-700
Diversity Index:> 1000
Ranking timeline:

European project participation (2000-01-01 - 2020-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 197
As coordinator: 12
As participant: 156
Sole participant: 29
Coordinator / Participant Ratio: 0.08*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2020 0 12.998.636 0 2
2019 16.057.200 56.823.039 11.912.024 5 8
2018 3.820.336 12.520.105 149.500 4 4
2017 9.376.250 8.759.860 4.500.000 2 4
2016 1.738.955 11.293.830 4.178.127 2 4
2015 2.168.794 38.787.645 6.127.881 2 8
2014 261.969 0 261.969 2
2013 6.195.747 35.879.301 4.334.619 3 7
2012 336.754 46.735.876 9.167.323 2 10
2011 8.098.428 25.638.979 3.387.602 3 5
2010 0 44.806.245 5.263.164 6
2009 258.694 42.684.009 5.434.181 2 8
2008 2.995.295 70.168.972 4.710.523 1 10
2007 0 13.617.101 1.073.768 4
2006 0 110.947.094 5.697.783 17
2005 8.644.181 71.065.443 7.821.825 5 14
2004 2.574.811 103.216.511 8.411.150 2 16
2003 0 5.424.475 633.279 4
2002 1.636.300 11.754.681 1.461.475 1 8
2001 2.846.897 5.459.524 1.456.652 4 6
2000 146.800 19.215.906 2.275.506 1 11
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE24
KAROLINSKA INSTITUTE22
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE17
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE16
EUROPEAN MOLECULAR BIOLOGY LABORATORY13
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD13
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER11
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE11
UNIVERSITY COLLEGE LONDON11
LUNDS UNIVERSITET10
MEDICAL RESEARCH COUNCIL10
UNIVERSITAETSKLINIKUM HEIDELBERG10
CHARITE UNIVERSITAETSMEDIZIN BERLIN9
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV8
INSTITUT CURIE7
ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI7
KATHOLIEKE UNIVERSITEIT LEUVEN7
RUPRECHT KARLS UNIVERSITAET HEIDELBERG7
UNIVERSITY OF BIRMINGHAM7
UNIVERSITY OF COPENHAGEN7
DANISH CANCER SOCIETY6
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM6
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR6
FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III6
INSTITUT PASTEUR6
LEIDEN UNIVERSITY MEDICAL CENTER6
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN6
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS6
THE UNIVERSITY OF MANCHESTER6
UNIVERSITY OF HELSINKI6
UPPSALA UNIVERSITET6
VTT TECHNICAL RESEARCH CENTRE OF FINLAND6
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS5
COMMISSARIAT A L'ENERGIE ATOMIQUE5
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH5
GENETHON5
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT5
KING'S COLLEGE LONDON5
UNIVERSITAET ZUERICH5
UNIVERSITAT AUTONOMA DE BARCELONA5
UNIVERSITEIT GENT5
UNIVERSITY OF AARHUS5
UNIVERSITY OF LEEDS5
VRIJE UNIVERSITEIT BRUSSEL5
ACIES SAS4
CENTRO DE INVESTIGACIONES ENERGETICAS MEDIOAMBIENTALES Y TECNOLOGICAS4
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS4
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER4
DEUTSCHES INSTITUT FUER ERNAEHRUNGSFORSCHUNG4
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE4
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V4
GATC BIOTECH4
IFOM FONDAZIONE ISTITUTO FIRC DI ONCOLOGIA MOLECOLARE4
INSTITUT CATALA D'ONCOLOGIA4
INSTITUT FUER MOLEKULARE BIOTECHNOLOGIE4
ISTITUTO EUROPEO DI ONCOLOGIA4
MEDIZINISCHE HOCHSCHULE HANNOVER4
MEDIZINISCHE UNIVERSITAET INNSBRUCK4
MEDIZINISCHE UNIVERSITAET WIEN4
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS4
THE UNIVERSITY OF WARWICK4
UNIVERSITE DE LAUSANNE4
UNIVERSITEIT UTRECHT4
UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY OF IRELAND DUBLIN4
UNIVERSITY OF GLASGOW4
UNIVERSITY OF OSLO4
UNIVERSITY OF TURKU4
ALBERT LUDWIGS UNIVERSITAET FREIBURG3
ARTTIC3
BARCELONA SUPERCOMPUTING CENTER CENTRO NACIONAL DE SUPERCOMPUTACION3
BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING3
CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES3
COMMISSION OF THE EUROPEAN COMMUNITIES DIRECTORATE GENERAL JOINT RESEARCH CENTRE JRC3
EBERHARDKARLSUNIVERSITAET TUEBINGEN3
EUROPAEISCHES INSTITUT FUER FORSCHUNG UND ENTWICKLUNG VON TRANSPLANTATIONSSTRATEGIEN3
FLANDERS INTERUNIVERSITY INSTITUTE FOR BIOTECHNOLOGY VZW3
FOUNDATION FOR GENOMICS & POPULATION HEALTH3
GEORG SPEYER HAUS CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT3
HELMHOLTZZENTRUM FUER INFEKTIONSFORSCHUNG3
INSERM TRANSFERT3
INSTITUT GUSTAVE ROUSSY3
ISTITUTO SUPERIORE DI SANITA3
KUNGLIGA TEKNISKA HOEGSKOLAN3
LUDWIG INSTITUT FUER KREBSFORSCHUNG3
MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN3
MOLECULAR MEDICINE3
NATIONAL UNIVERSITY OF IRELAND GALWAY3
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON3
TECHNISCHE UNIVERSITAET MUENCHEN3
THE BABRAHAM INSTITUTE3
THE HEBREW UNIVERSITY OF JERUSALEM3
THE UNIVERSITY OF EDINBURGH3
THE UNIVERSITY OF LIVERPOOL3
UNIVERSIDAD DE NAVARRA3
UNIVERSITA DEGLI STUDI DI MILANO BICOCCA3
UNIVERSITA DEGLI STUDI DI NAPOLI FEDERICO II3
UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA3
UNIVERSITA VITA SALUTE SAN RAFFAELE3
UNIVERSITAET BERN3
UNIVERSITAETSKLINIKUM FREIBURG3
Constancy:

Total number of partners:1489

Partner loyalty:
Frequent Partner: (> 2 projects): 571
Rare Partner: 918

Frequent / Rare Partner Ratio: 0.62

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES77
RTD HORIZONTAL TOPICS36
SOCIAL AND ECONOMIC CONCERNS22
INDUSTRY AND TECHNOLOGY4
AGRICULTURE AND MARINE RESOURC4
PROTECTING MAN AND HIS ENVIRON1

Project overview:

Start dateProjectacronymrolefundingpartners
2020-01-01HCA|Organoid: Pilot action to establish a multi-tissue human organoid platform within the Human Cell Atlas as a booster of future disease-centric, mechanistic, and translational research HCA Organoidparticipant4.998.6888
2020-01-014-IN THE LUNG RUN: towards INdividually tailored INvitations, screening INtervals, and INtegrated co-morbidity reducing strategies in lung cancer screening 4-IN THE LUNG RUNparticipant7.999.9499
2019-07-01Decoding Context-Dependent Genetic Networks in vivo DECODEcoordinator10.625.0003
2019-06-01The strong interaction at the frontier of knowledge: fundamental research and applications STRONG-2020participant10.000.00044
2019-05-01Matching CNS Lineage Maps with Molecular Brain Tumor Portraits for Translational Exploitation BRAIN-MATCHcoordinator1.999.8751
2019-03-01European network staff eXchange for integrAting precision health in the health Care sysTems ExACTparticipant1.090.20017
2019-02-01Safeguarding Cell Fate by Terminal Repression during Development and Disease SafeFatecoordinator1.761.4891
2019-02-01European Advanced infraStructure for Innovative Genomics EASI-Genomicsparticipant9.991.26716
2019-01-24Clarifying role of the CENTROSOME in abnormal mitotic processes featuring the most commonchildhood malignancy: paediatric High Hyperdiploid Acute Lymphoblastic Leukaemia (HHDpALL) CENTR-ALLcoordinator171.4611
2019-01-01Project on Exercise for Fatigue Eradication in Advanced Breast cancer to improve quality of life PREFERABLEparticipant3.983.34712
2019-01-01individualizedPaediatricCure: Cloud-based virtual-patient models for precision paediatric oncology iPCparticipant14.748.40021
2019-01-01EUCANCan: a federated network of aligned and interoperable infrastructures for the homogeneous analysis, management and sharing of genomic oncology data for Personalized Medicine. EUCANCanparticipant5.999.45318
2019-01-01Targeting genetic and epigenetic mechanisms in pediatric sarcomas. PedSarccoordinator1.499.3751
2019-01-01Translational studies of HEAD and neck cancer in South America and Europe HEADSpAcEparticipant3.153.44815
2019-01-01ARCHITECTURE AND TOOLS FOR THE QUERY OF ANTIBODY AND T-CELL RECEPTOR SEQUENCING DATA REPOSITORIES FOR ENABLING IMPROVED PERSONALIZED MEDICINE AND IMMUNOTHERAPY iReceptor Plusparticipant7.856.92520
2018-09-01Quantitative T cell Immunology and Immunotherapy QuanTIIparticipant3.923.65310
2018-08-01Mechanisms of vascular maturation and quiescence during development, homeostasis and aging AngioMatureparticipant2.338.9182
2018-08-01Image-based analysis for drug discovery and repurposing REMATCHcoordinator149.5001
2018-07-01Mechanism and vulnerability of BAP1 loss in tumor metastasis VulneraBAP1coordinator171.4611
2018-06-01Redirecting glial progenitor fate to rebuild the injured Brain REBUILDCNScoordinator2.000.0001
2018-06-01Come and Play Science at European Researchers` Night QriUSparticipant307.57010
2018-06-01Exploring cell interactions in the tumor microenvironment with dual ribosome profiling DualRPcoordinator1.499.3751
2018-01-01Systems Medicine of Metabolic-Signaling Networks: A New Concept for Breast Cancer Patient Stratification MESI-STRATparticipant5.949.96415
2017-10-01A new era in personalised medicine: Radiomics as decision support tool for diagnostics and theragnostics in oncology PREDICTparticipant3.860.06018
2017-10-01Detecting, understanding and exploiting intracellular redox signaling relays Redox Relayscoordinator2.006.2501
2017-09-01Centre of Excellence in Digital Health and Personalised Medicine Clinnovaparticipant399.8005
2017-07-01Endogenous barcoding for in vivo fate mapping of lineage development in the blood and immune system BARCODED-CELLTRACINGparticipant2.500.0001
2017-03-01Regulation of Cellular Growth and Metabolism by C18:0 C18Signalingparticipant2.000.0001
2017-01-01ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064 ITCC-P4coordinator7.370.00021
2016-11-07Deciphering the machinery involved in stability of the transcription factor HOXA9. HOXA9 degradomecoordinator239.8611
2016-06-01Overcoming the epigenetic and therapeutic barrier of EVI1-overexpressing cancers EVI1inCancercoordinator1.499.0941
2016-01-01European Regulatory Science on Tobacco:Policy implementation to reduce lung diseases EUREST-PLUSparticipant2.325.54513
2016-01-01Mechanisms underlying hepatocellular carcinoma pathogenesis and impact of co-morbidities. HEP-CARparticipant5.698.31010
2016-01-01RNA EDITING IN HEALTH AND DISEASE RNAEDITparticipant2.270.0003
2016-01-01Towards outstanding research and training in tumour biology at IMM ReTuBiparticipant999.9753
2015-10-01implementAtion anD OPeration of the gateway for healTh into BBMRI-ERIC ADOPT BBMRI-ERICparticipant4.949.44923
2015-09-01Statistical multi-Omics UNDerstanding of Patient Samples SOUNDparticipant2.953.06313
2015-09-01Coordinated Research Infrastructures Building Enduring Life-science services CORBELparticipant14.837.80039
2015-09-01Breast CAncer STratification: understanding the determinants of risk and prognosis of molecular subtypes B-CASTparticipant5.983.35613
2015-07-01Computational Biophotonics for Endoscopic Cancer Diagnosis and Therapy COMBIOSCOPYparticipant1.499.6993
2015-07-01Regulating the immune regulators: targeting adaptive immune control REGiREGparticipant1.955.0001
2015-06-01Dissection of tumor heterogeneity in vivo CancerHeterocoordinator2.000.0001
2015-01-01Development of Selective Carbohydrate Immunomodulators Targeting C-type Lectin Receptors on Antigen Presenting Cells IMMUNOSHAPEparticipant3.811.58115
2015-01-01The RANK-Axis in Breast Cancer: A comprehensive prospective evaluation of promising novel biomarkers RANKL_OPGcoordinator168.7941
2015-01-01Epigenetic regulation of endocrine therapy resistance in breast cancer: A systems medicine approach to predict treatment outcome EpiPredictparticipant2.797.6978
2014-09-01Identifying and characterising transmembrane transporters of tryptophan and kynurenine in normal and cancerous brain tissue KP TRANSPORTcoordinator161.9691
2014-04-01Mechanisms of Mismatch repair inactivation and identification of genes suppressing mutations IMMRcoordinator100.0001
2013-11-01Immunostimulatory Agonist antibodies for Cancer Therapy IACTcoordinator5.995.74710
2013-10-01Validating predictive models of radiotherapy toxicity to improve quality-of-life and reduce side-effects in cancer survivors REQUITEparticipant5.997.40815
2013-09-01T-cell based immunotherapy in pancreatic cancer - basic concepts and pre-clinical development TIPC_TIL_IPcoordinator100.0001

overview shows latest 50 from 197 projects (2000-01-01 - 2020-12-31)
A full list of projects can be found here:

Alias institution names:
  • DEUTSCHES KREBSFORSCHUNGSZENTRUM
  • DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG
  • GERMAN CANCER RESEARCH CENTER

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum